tiprankstipranks
Guided Therapeutics Inc (GTHP)
OTHER OTC:GTHP
US Market

Guided Therapeutics (GTHP) Financial Statements

28 Followers

Guided Therapeutics Financial Overview

Guided Therapeutics's market cap is currently $23.12M. The company's EPS TTM is $-0.045; its P/E ratio is -12.65; Guided Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 7.00K$ 98.00K$ 13.00K$ 81.00K
Gross Profit$ 571.00K$ 2.00K$ 36.00K$ -68.00K$ 20.00K
Operating Income$ -2.37M$ -2.11M$ -3.46M$ -3.33M$ -2.36M
EBITDA$ -2.37M$ -1.94M$ -3.13M$ -3.69M$ -919.00K
Net Income$ -3.35M$ -2.42M$ -3.49M$ -4.34M$ -2.07M
Balance Sheet
Cash & Short-Term Investments$ 63.00K$ 388.00K$ 591.00K$ 2.31M$ 643.00K
Total Assets$ 1.32M$ 1.38M$ 1.67M$ 3.37M$ 2.04M
Total Debt$ 2.92M$ 2.16M$ 2.06M$ 2.26M$ 2.90M
Net Debt$ 2.86M$ 1.77M$ 1.47M$ -50.00K$ 2.26M
Total Liabilities$ 694.00K$ 6.27M$ 5.47M$ 6.25M$ 7.49M
Stockholders' Equity$ 630.00K$ -4.89M$ -3.81M$ -2.88M$ -5.45M
Cash Flow
Free Cash Flow$ -1.07M$ -1.12M$ -1.75M$ -1.51M$ -1.61M
Operating Cash Flow$ -1.07M$ -1.12M$ -1.75M$ -1.48M$ -1.59M
Investing Cash Flow$ -2.00K$ 0.00$ 0.00$ -31.00K$ -14.00K
Financing Cash Flow$ 745.00K$ 916.00K$ 24.00K$ 3.18M$ 2.07M
Currency in USD

Guided Therapeutics Earnings and Revenue History

Guided Therapeutics Debt to Assets

Guided Therapeutics Cash Flow

Guided Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.